PLRX
Price
$1.86
Change
+$0.23 (+14.11%)
Updated
Sep 5 closing price
Capitalization
114.18M
66 days until earnings call
PTGX
Price
$60.53
Change
+$0.93 (+1.56%)
Updated
Sep 5 closing price
Capitalization
3.77B
60 days until earnings call
Interact to see
Advertisement

PLRX vs PTGX

Header iconPLRX vs PTGX Comparison
Open Charts PLRX vs PTGXBanner chart's image
Pliant Therapeutics
Price$1.86
Change+$0.23 (+14.11%)
Volume$3.43M
Capitalization114.18M
Protagonist Therapeutics
Price$60.53
Change+$0.93 (+1.56%)
Volume$1.93M
Capitalization3.77B
PLRX vs PTGX Comparison Chart in %
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. PTGX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Buy and PTGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (PLRX: $1.86 vs. PTGX: $60.53)
Brand notoriety: PLRX and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 312% vs. PTGX: 266%
Market capitalization -- PLRX: $114.18M vs. PTGX: $3.77B
PLRX [@Biotechnology] is valued at $114.18M. PTGX’s [@Biotechnology] market capitalization is $3.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whilePTGX’s FA Score has 1 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • PTGX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTGX is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 4 TA indicator(s) are bullish while PTGX’s TA Score has 5 bullish TA indicator(s).

  • PLRX’s TA Score: 4 bullish, 4 bearish.
  • PTGX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а +13.41% price change this week, while PTGX (@Biotechnology) price change was +2.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PLRX is expected to report earnings on Nov 11, 2025.

PTGX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($3.77B) has a higher market cap than PLRX($114M). PTGX YTD gains are higher at: 56.813 vs. PLRX (-85.877). PTGX has higher annual earnings (EBITDA): 26.8M vs. PLRX (-201.76M). PTGX has more cash in the bank: 570M vs. PLRX (263M). PTGX has less debt than PLRX: PTGX (11.3M) vs PLRX (60.4M). PTGX has higher revenues than PLRX: PTGX (209M) vs PLRX (0).
PLRXPTGXPLRX / PTGX
Capitalization114M3.77B3%
EBITDA-201.76M26.8M-753%
Gain YTD-85.87756.813-151%
P/E RatioN/A82.92-
Revenue0209M-
Total Cash263M570M46%
Total Debt60.4M11.3M535%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
64
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXPTGX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGWFX15.670.10
+0.64%
Transamerica Large Growth R4
ALGRX102.910.21
+0.20%
Alger Focus Equity I
DILRX18.86N/A
N/A
DFA International Large Cap Growth
SNORX36.61N/A
N/A
Easterly Snow Long/Short Opportunity R6
TIEIX45.63N/A
N/A
Nuveen Equity Index R6

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with OCUL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+14.11%
OCUL - PLRX
41%
Loosely correlated
+7.09%
SRRK - PLRX
40%
Loosely correlated
-3.18%
LXRX - PLRX
39%
Loosely correlated
+1.87%
RIGL - PLRX
38%
Loosely correlated
+3.02%
SLDB - PLRX
37%
Loosely correlated
-1.08%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been closely correlated with BIESF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTGX jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+1.56%
BIESF - PTGX
66%
Closely correlated
N/A
TRVI - PTGX
44%
Loosely correlated
-3.04%
MLYS - PTGX
39%
Loosely correlated
+5.07%
FULC - PTGX
38%
Loosely correlated
+11.34%
PLRX - PTGX
35%
Loosely correlated
+14.11%
More